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SUMMARY
It is common in medical studies that the outcome of interest is truncated by death, meaning that a subject
has died before the outcome could be measured. In this case, restricted analysis among survivors may be
subject to selection bias. Hence, it is of interest to estimate the survivor average causal effect, defined as the
average causal effect among the subgroup consisting of subjects who would survive under either exposure.
In this paper, we consider the identification and estimation problems of the survivor average causal effect.
We propose to use a substitution variable in place of the latent membership in the always-survivor group.
The identification conditions required for a substitution variable are conceptually similar to conditions
for a conditional instrumental variable, and may apply to both randomized and observational studies. We
show that the survivor average causal effect is identifiable with use of such a substitution variable, and
propose novel model parameterizations for estimation of the survivor average causal effect under our
identification assumptions. Our approaches are illustrated via simulation studies and a data analysis.
Some key words: Causal inference; Instrumental variable; Model parameterization; Principal Stratification; Survivor
average causal effect.
1. INTRODUCTION
In medical studies, researchers are often interested in evaluating risk factors for a non-mortality
outcome. However, this outcome may be truncated by death and hence, undefined if some subjects
die before the follow-up assessment. For example, suppose we are interested in estimating the effect
of smoking on memory decline in an aged population. If a subject dies before the follow-up memory
test is administered, then his/her memory score at the follow-up visit is undefined. Direct comparisons
between smokers and non-smokers among observed survivors are subject to selection bias, as non-smokers
are more likely to survive to the follow-up assessment, and survival is associated with memory
decline (Rosenbaum, 1984; Robins & Greenland, 1992). More fundamentally, direct comparisons among
observed survivors are not causally interpretable, as they compare outcomes from different subpopulations
at baseline (Rubin, 2006). Robins (1986, §12.2) proposed to estimate the average causal effect in the
always-survivor group, the group of subjects who would survive if they chose to receive either exposure
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at baseline. The always-survivor group was later termed a principal stratum by Rubin (1998) and Frangakis
& Rubin (1999, 2002), and the contrast within this group is the survivor average causal effect. This contrast
is causally interpretable because membership of the always-survivor group is defined at baseline, and
since these subjects always survive, their subsequent outcomes under both treatments are well-defined.
Alternative estimands are discussed in Kurland et al. (2009) and Weuve et al. (2012).
The survivor average causal effect is not identifiable without further assumptions (Zhang & Rubin,
2003). Large sample bounds for the survivor average causal effect have been derived under minimal
assumptions (Zhang & Rubin, 2003; Imai, 2008; Long & Hudgens, 2013). In order to identify this effect,
it is common to perform a sensitivity analysis by assuming a class of identification conditions indexed by
a sensitivity parameter (Gilbert et al., 2003; Shepherd et al., 2006; Hayden et al., 2005; Egleston et al.,
2007; Jemiai et al., 2007; Chiba & VanderWeele, 2011).
Alternatively, identification of the survivor average causal effect can be based on covariate information.
For example, Tchetgen Tchetgen (2014) introduced a variant of the survivor average causal effect that is
identified when risk factors of survival are available in post-exposure follow-ups. The resulting causal
contrast is for a principal stratum defined in term of particular post-exposure risk factors. Hence, in
principle, the causal estimand can differ depending on the set of post-exposure risk factors used in
the analysis. Ding et al. (2011) took a different approach to identifying the survivor average causal
effect in a randomized study setting. They proposed a semiparametric identification method based on
a baseline variable whose distribution is informative of the membership of the always-survivor group.
Using this baseline variable, they showed that the survivor average causal effect was identifiable under
their assumptions. However, as pointed out by Tchetgen Tchetgen (2014), their assumption essentially
requires that there are no common causes of the survival and outcome processes, which is very unlikely
even in randomized studies.
In this article, we relax Ding et al. (2011)’s identification assumptions by employing more detailed
covariate information. In contrast to Tchetgen Tchetgen (2014)’s estimand, our causal parameter is defined
independently of the covariates incorporated in the analysis. Furthermore, the proposed approach is
applicable to both randomized trials and observational studies, and allows for measured common causes
of the survival and outcome processes. We also discuss possible violations and alternative approaches to
our identification model. To estimate the survivor average causal effect in practice, we impose additional
distributional assumptions. This is challenging for two reasons. First, unlike the standard observational
study setting, in our identification framework, the baseline covariates may be common causes between
any pair of treatment, survival and outcome. As we explain in Section 4, this unique role for baseline
covariates makes the standard propensity score methods inappropriate in our setting. Second, novel model
parameterizations are needed to make our distributional assumptions compatible with our identification
assumptions.
2. DATA STRUCTURE, NOTATION AND CAUSAL ESTIMAND
Consider a medical study with a single follow-up visit. Let Z be the exposure indicator and W denote
covariates observed at baseline. We assume that each subject has two potential survival outcomes S(1)
and S(0), defined as the survival statuses at the follow-up visit that would have been observed had the
subject been exposed and unexposed, respectively. Similarly we let Y (1) and Y (0) denote the potential
non-mortality outcomes under exposure and non-exposure, respectively. We assume that for z = 0,1, Y (z)
takes real values only if S(z) = 1. We extend the definition of Y (z) so that it takes the constant value ∗ if
S(z) = 0.
We use G to denote the survival type as defined in Table 1, in which L denotes live and D denotes
die. One can see from Table 1 that there exists a one-to-one mapping between the survival type and the
bivariate potential survival {S(1), S(0)}, so G can be interpreted as an abbreviation for {S(1), S(0)}.
We adopt the axiom of consistency such that the observed outcome Y satisfies Y = ZY (1) + (1 −
Z)Y (0) and the observed survival S satisfies S = ZS(1) + (1 −Z)S(0). The observed samples Oi =(Zi,Wi, Si, Yi), i = 1, . . . ,N are independently drawn from an infinite super-population.
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Table 1: Patient survival types
S(1) S(0) Survival type G Description
1 1 always-survivor LL The subject always survives, regardless of exposure status.
1 0 protected LD The subject survives if exposed, but dies if not exposed.
0 1 harmed DL The subject dies if exposed, but survives if not exposed.
0 0 doomed DD The subject always dies, regardless of exposure status.
Throughout this article, we assume that there is no interference between study subjects regarding both
the survival S and the non-mortality outcome Y , and there is only one version of exposure (Rubin, 1980).
Rubin (2000) noted that the observed survivors in the exposed group are from a mixture of
always-survivor and protected strata, while the observed survivors in the non-exposed group are from
a mixture of always-survivor and harmed strata. As a result, direct comparisons between different
exposure groups among observed survivors are not causally meaningful as these people are from different
subpopulations at baseline. To address this, since the always-survivor stratum is the only group for which
Y (1) and Y (0) both take real values, we define our causal estimand to be the average causal effect in this
stratum:
∆LL = E{Y (1) − Y (0) ∣ G = LL}.
This estimand is also known as the survivor average causal effect.
3. IDENTIFICATION OF THE SURVIVOR AVERAGE CAUSAL EFFECT
3⋅1. The identification problem
Though causally interpretable, the survivor average causal effect is in general not identifiable as it
depends on the potential outcomes Y (1), Y (0), S(1) and S(0). Furthermore, it is not identifiable even
under assumptions that are sufficient for identification in other causal contexts:
A.1 (Monotonicity) S(1) ≥ S(0) almost surely.
The monotonicity assumption may be plausible in some observational studies. For example, in studies
evaluating the effect of smoking on memory decline, it is widely believed that smoking is bad for overall
health, and hence overall survival. This assumption tends to be questionable in randomized clinical trials
with acute diseases because typically a clinical trial would be unethical if the researchers believe that one
treatment benefits survival a priori. To address this issue, we relax this assumption later in Section 3⋅4.
A.2 (S-Ignorability) The treatment assignment is independent of the potential survivals given the
observed covariates W , so that Z⊥⊥S(z) ∣W ; z = 0,1.
A.3 (Y-Ignorability) The treatment assignment in the always-survivor stratum is independent of the
potential outcomes given observed covariates W , so that Z⊥⊥Y (z) ∣W,G = LL; z = 0,1.
A.2 and A.3 are similar to the weakly ignorable treatment assignment assumption (see e.g., Imbens, 2000).
Under A.3, we have
E{Y (z) ∣ G = LL} = EW (µz,LL,WpiLL∣W )
EW (piLL∣W ) , (1)
where µz,g,W = E(Y ∣ Z = z,G = g,W ) and pig∣W = pr(G = g ∣W ). Under A.1 and A.2,
Z⊥⊥(S(1), S(0)) ∣W , so the W -specific survival-type probabilities are identified by
piLL∣W = pr(S = 1 ∣ Z = 0,W ), piLD∣W = pr(S = 1 ∣ Z = 1,W ) − pr(S = 1 ∣ Z = 0,W ); (2)
µ0,LL,W can be identified by
µ0,LL,W = E(Y ∣ Z = 0, S = 1,W ). (3)
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However, µ1,LL,W is not identifiable from the observed data. In fact, as noted by Zhang & Rubin (2003),
the observed data in the group {i ∶ Zi = 1, Si = 1,Wi = wi} can be written as a mixture of two distributions
from the LL and LD strata:
F (y ∣ Z = 1, S = 1,W ) = ∑
g=LL,LD pg∣1,W,s=1F (y ∣ Z = 1,G = g,W ),
where F denotes the cumulative distribution function, and for g = LL or LD, pg∣z,W,s=1 ≡ pr(G = g ∣
W )/pr(S = 1 ∣ Z = z,W ) is identifiable from data. Unless the mixing probability pLL∣1,w is 1 or 0,
µ1,LL,W is only partially identifiable in that there is a range of values for µ1,LL,W that are compatible
with the observed data distribution.
3⋅2. Identifying the survivor average causal effect using a substitution variable
To identify the survivor average causal effect, without loss of generality, we assume that the baseline
covariates W can be written as (X,A). We propose an identification framework in which the role of X is
similar to a confounder whereas that of A is similar to an instrument. Specifically, we make the following
assumptions on A and X:
A.4 (Exclusion restriction) A⊥⊥Y (1) ∣ Z = 1,G,X.
A.5 (Substitution relevance) A /⊥⊥ G ∣ Z = 1, S = 1,X.
The survival type G is a latent baseline variable that satisfies A.4 and A.5. For this reason, any variable
A satisfying A.4 and A.5 is called a substitution variable for G. The conditions for a substitution variable
are similar to those for an instrumental variable (Angrist et al., 1996). Specifically, A.4 is similar to
the exclusion restriction assumption in an instrumental variable analysis in that they both capture the
notion of A having no direct effect on Y , and A.5 is similar to the instrumental relevance assumption;
in particular, they both require that A be a relevant variable. We clarify that similar to the instrumental
relevance assumption, A.5 needs to hold for all possible values of X . As we illustrate in Section 3⋅3,
even in a randomized study setting, the inclusion of covariate information X makes A.4 and A.5 more
plausible.
Theorem 1 below states that the survivor average causal effect is identifiable with a substitution variable
for the survival type. Proofs of theorems are left to the Supplementary Material.
THEOREM 1. Under A.1–A.5, ∆LL is identifiable.
When A takes more than two values, ∆LL may be over-identified. In this case, one may falsify our
identification assumptions using specification tests such as the Sargan–Hansen test.
3⋅3. A nonparametric structural equation model with independent errors
The key assumptions in our identification model are A.2–A.4. These are implied by a certain
nonparametric structural equation model with independent errors (Pearl, 2009) given by
X = fX(X),A = fA(X, A), Z = fZ(X,A, Z), S = fS(X,A,Z, S), Y = fY (X,Z,S, Y ), (4)
where the error terms X , A, Z , S , Y are jointly independent. Here the error terms can be interpreted as
the set of one-step-ahead counterfactuals; for example, Z can be interpreted as {Z(a, x) ∶ a ∈ A, x ∈ X},
whereA andX are the sample space forA andX , respectively. Figure 1 gives the simplest causal diagram
associated with (4). There is no directed edge from A to Y , encoding the notion that A has no direct effect
on Y . We remark that A.2–A.4 also follow from (4) with dependent errors that allow for unmeasured
confounding between nodes in Fig. 1. See the Supplementary Material for examples.
In contrast to the identification assumptions in Ding et al. (2011), we include baseline covariates X in
our identification framework. Our approach is applicable to observational studies since we allow for the
edge X → Z. Moreover, we allow for edges X → S and X → Y , thereby avoiding the assumption that
there are no common causes of the survival and outcome processes, which is very restrictive even for
randomized studies.
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X A Z S Y
Fig. 1: The simplest causal diagram associated with the structural equations (4).
Remark 1. The assumptions of a nonparametric structural equation model with independent errors
cannot be tested, even in principle, via any randomized experiment on the measured variables (Robins
& Richardson, 2010).
3⋅4. Alternatives to the individual-level monotonicity assumption
We now consider alternative stochastic monotonicity assumptions in place of the individual-level
assumption A.1. These alternatives were used by Roy et al. (2008) in the context of non-compliance
and by Lee et al. (2010) in the context of truncation by death.
We characterize the association between the potential survivals S(1) and S(0) by
ρ(W ) = pr(G = LL ∣W ) − pr{S(1) = 1 ∣W}pr{S(0) = 1 ∣W}
min[pr{S(1) = 1 ∣W},pr{S(0) = 1 ∣W}] − pr{S(1) = 1 ∣W}pr{S(0) = 1 ∣W} .
Note that ρ(W ) is no larger than 1 and differs from the correlation between S(1) and S(0) by a
non-negative identifiable factor. In particular, the sign of ρ(W ) coincides with the sign of the conditional
correlation cor{S(1), S(0) ∣W}. In practice, one might be willing to assume that the potential survivals
under active treatment and control are not negatively correlated such that
pr{S(1) = 1 ∣ S(0) = 1,W} ≥ pr{S(1) = 1 ∣ S(0) = 0,W}
almost surely. This gives rise to the following stochastic monotonicity assumption:
A.6 (Stochastic monotonicity)
0 ≤ ρ(W ) ≤ 1
almost surely.
Note that ρ(W ) = 0 if and only if conditional on observed covariates W , S(1) is not
correlated with S(0). On the other hand, ρ(W ) = 1 if and only if pr(G = LL ∣W ) =
min [pr{S(1) = 1 ∣W},pr{S(0) = 1 ∣W}]. We emphasize that A.6 does not reduce to A.1 when
ρ(W ) = 1; in particular, assuming a value for ρ(W ) ∈ [0,1] does not specify which treatment is more
beneficial for survival. This is particularly appealing when the monotonicity assumption is not plausible
a priori due to ethical reasons.
Theorem 2 states that under A.2–A.6, if we further assume that A.4 and A.5 hold in the control arm,
then given ρ(W ), the survivor average causal effect is identifiable from the observed data. The additional
conditional independence condition (i) in Theorem 2 also follows from the structural equation model (4)
with independent errors.
THEOREM 2. If we assume A.2–A.6, and that
(i) A⊥⊥Y (0) ∣ Z = 0,G,X;
(ii) for all x ∈ X , A /⊥⊥ G ∣ Z = 0, S = 1,X = x,
then ∆LL is identifiable given ρ(W ).
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3⋅5. Relaxing the exclusion restriction assumption
In practice, the ignorability assumptions A.2 and A.3 may be questionable if there are unmeasured
confounders between the exposure Z and either the survival S or the non-mortality outcome Y . Similarly,
the exclusion restriction assumption A.4 may be questionable if the set of observed covariates X is not
rich enough to contain all common causes of the non-mortality outcome and any one of the treatment,
the substitution variable and survival. There has been extensive literature on relaxing the ignorability
assumptions for causal inference in observational studies (see e.g., Rosenbaum & Rubin, 1983; Imbens,
2003; Ding & Vanderweele, 2014), which may be applied here with slight modification. Hence in this
article, we focus on alternative assumptions to relax the exclusion restriction assumption.
Specifically, we propose an alternative no-interaction assumption A.7, which assumes that conditioning
on the baseline variables X , neither Z nor G modifies the effect of A on Y .
A.7 (no-interaction) For all x, a0, a1,
E(Y ∣ Z = 1,G = LD,X = x,A = a1) −E(Y ∣ Z = 1,G = LD,X = x,A = a0) (5)= E(Y ∣ Z = 1,G = LL,X = x,A = a1) −E(Y ∣ Z = 1,G = LL,X = x,A = a0) (6)= E(Y ∣ Z = 0,G = LL,X = x,A = a1) −E(Y ∣ Z = 0,G = LL,X = x,A = a0). (7)
In contrast, the exclusion restriction assumption A.4 implies that the comparisons in (5) and (6) are both
0.
This no-interaction assumption may be plausible when the substitution variable affects the outcome
independently of other disease processes. For example, suppose one is interested in studying the effects
of statin usage on memory decline, taking baseline dementia status as the substitution variable. It is likely
that baseline dementia status will affect the outcome directly as memory decline is an irreversible process:
demented subjects are more likely to experience decline in memory. However, it seems reasonable to
assume that neither statin usage, which is typically due to high blood cholesterol levels, nor the latent
survival statuses, which largely reflect baseline cholesterol levels, would interact, on the additive scale,
with the process of memory decline.
To relax A.4 in the absence of X , Ding et al. (2011) also assumed that (5) is equal to (6). In addition,
they placed linearity assumptions onE(Y ∣ Z = 1,G,A), and required that the substitution variableA had
at least three categories or was continuous. Both assumptions may be overly restrictive in practice. For
example, they may not hold in the example of statin usage and memory decline described above, taking
A to be dementia status at baseline. This is because current knowledge on dementia suggests that baseline
cognitive status has a non-linear influence on the deterioration of cognitive score (e.g., Sperling et al.,
2014); in addition, baseline dementia status is often coded as a binary variable. To mitigate the need for
linearity identification assumptions and allow for binary substitution variables, we instead assume that (6)
is equal to (7); that is, Z is not an effect modifier for the conditional effect of A on Y . This is similar in
spirit to the no-interaction assumption in causal mediation analysis (e.g., Robins, 2003). In particular, it is
guaranteed to hold under the strong null of no treatment effect of Z on Y .
The inclusion of baseline covariates in A.7 has important implications for the design of studies with
truncation by death: every possible cause of the outcome should be measured, if feasible, to try to ensure
that no residual effect modification remains within strata defined by X .
Theorem 3 states that if we replace the exclusion restriction assumption A.4 with A.7, then the survivor
average causal effect is still identifiable.
THEOREM 3. Under assumptions A.1–A.3, A.5 and A.7, ∆LL is identifiable.
4. MODEL PARAMETERIZATION
In the previous section we have shown that the survivor average causal effect is identifiable under
various identification assumptions. When the covariates W take only a few discrete values, within each
level of X , the identification formulae in the proofs of Theorem 1–3 imply plug-in estimators in the case
of binary A and generalized method of moment estimators in the case that A takes more than two discrete
Causal Inference with Truncation by Death 7
values (Ding et al., 2011; Hansen, 1982). When W are continuous or high dimensional, however, we need
to impose additional distributional assumptions. We first note that the identification assumptions imply
certain constraints on the observed data law, as described in Proposition 1.
PROPOSITION 1.
(I) The assumptions of Theorem 1 imply the following constraints on the law of (Z,S,Y,W ):
pr(S = 1 ∣ Z = 0,X,A) ≤ pr(S = 1 ∣ Z = 1,X,A); (8)
for all x,E(Y ∣ Z = 1, S = 1,X = x,A = a) is bounded as a function of a; (9)
for all x,
pr(S = 1 ∣ Z = 0,X = x,A = a)
pr(S = 1 ∣ Z = 1,X = x,A = a) is not constant as a function of a. (10)
(II) The assumptions of Theorem 2 imply (9) and that
for all x,E(Y ∣ Z = 0, S = 1,X = x,A = a) is bounded as a function of a. (11)
(III) The assumptions of Theorem 3 imply (8) and that
for all x,E(Y ∣ Z = 1, S = 1,X = x,A = a) −E(Y ∣ Z = 0, S = 1,X = x,A = a)
is bounded as a function of a. (12)
To ensure that the modeling assumptions are compatible with the constraints in Proposition 1, we
avoid imposing distributional assumptions on the observed data directly. Instead, we make the following
distributional assumptions on the law of {Z,W,S(1), S(0), Y (1), Y (0)}, which are compatible with the
identification assumptions. For brevity here we only give models under the assumptions of Theorem 1.
Parameterizations for estimating ∆LL under alternative identification assumptions which are similar in
spirit are described in Appendix A.
M.1 E{Y (0) ∣ Z = 0,G = LL,X,A} is known up to a finite-dimensional parameter α1; that is,
E{Y (0) ∣ Z = 0,G = LL,X,A} =m1(X,A;α1), where m1(⋅, ⋅;α1) is a known function and α1
is an unknown parameter. Specifically, for the simulations and data example we consider
m1(X,A;α1) = α10 +XTα11 +Aα12. (13)
M.2 E{Y (1) ∣ Z = 1,X,G,A} is known up to a finite-dimensional parameter α2; that is, E{Y (1) ∣ Z =
1,X,G,A} =m2(X,G;α2), where G takes values in {LL,LD}, m2(⋅, ⋅;α2) is a known function
and α2 is an unknown parameter. Note that due to A.4, E{Y (1) ∣ Z = 1,X,G,A} does not depend
on the value of A. Specifically, for the simulations and data example we code LL to be 1, LD to be
0, and consider
m2(X,G;α2) = α20 +XTα21 +Gα23. (14)
M.3 pr{S(1) = 1 ∣X,A} is known up to a finite-dimensional parameter β1; that is pr{S(1) = 1 ∣
X,A} = θ1(X,A;β1), where θ1(⋅, ⋅;β1) is a known function and β1 is an unknown parameter.
Specifically, for the simulations and data example we consider
θ1(X,A;β) = expit(β10 +XTβ11 +Aβ12). (15)
M.4 pr{S(0) = 1 ∣X,A}/pr{S(1) = 1 ∣X,A} is known up to a finite-dimensional parameter γ; that is
pr{S(0) = 1 ∣X,A}/pr{S(1) = 1 ∣X,A} = θ0/1(X,A;γ), where θ0/1(⋅, ⋅;γ) is a known function
and γ is an unknown parameter. Specifically, for the simulations and data example we consider
θ0/1(X,A;γ) = expit(γ0 +XT γ1 +Aγ2). (16)
An alternative approach to M.3 and M.4 is to impose distributional assumptions on pr{S(z) ∣X,A},
z = 0,1 directly (e.g., Lee et al., 2010). However, constraint (8) implies that pr{S(0) = 1 ∣X,A} resides
in the range [0,pr{S(1) = 1 ∣X,A}]. Hence the model parameters for pr{S(1) = 1 ∣X,A} live in a
constrained space, making estimation and asymptotic analysis difficult. To avoid such constraints, we
reparameterize our models as in M.3 and M.4.
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To derive the maximum likelihood estimator, we note that M.1–M.4 correspond to the following
modeling constraints on the observed data distribution:
pr(S = 1 ∣ Z = 1,X,A) = θ1(X,A;β1),
pr(S = 1 ∣ Z = 0,X,A) = θ1(X,A;β1)θ0/1(X,A;γ),
E(Y ∣ Z = 1, S = 1,X,A) = θ0/1(X,A;γ)m2(X,1;α2) + {1 − θ0/1(X,A;γ)}m2(X,0;α2),
E(Y ∣ Z = 0, S = 1,X,A) =m1(X,A;α1).
It is easy to see that these models are compatible with the testable implications described in Proposition
1. Ordinary least squares and maximum likelihood estimation may be used for the parameter estimation.
∆LL can then be estimated using (1), in which µz,LL,W can be estimated using (13) and (14), piLL∣W can
be estimated using the product of (15) and (16), and the integration is taken with respect to the empirical
distribution of W . Using standard M-estimation theory, one can show that the resulting estimate of ∆LL
is consistent and asymptotically normally distributed.
Remark 2. An alternative popular approach to estimating causal effects is based on the propensity score
e(X), defined as the probability of assignment to exposure conditioning on baseline covariates. However,
although the propensity score is sufficient for summarizing the effect of X on Z in the sense that Z⊥⊥X ∣
e(X), it is not sufficient for summarizing the effect ofX onA. Thus the propensity score methods are not
directly applicable for estimating the survivor average causal effect under our identification assumptions.
5. SIMULATION STUDIES
5⋅1. Settings following A.1–A.5
We first consider simulation settings in which data were generated according to Fig. 1. Specifically the
baseline covariates X = (X1,X2,X3) are a combination of discrete and continuous variables: X1 is a
discrete variable taking values 1 or -1 with probability 1/2, and (X2,X3) follows a multivariate normal
distribution N(µ,Σ), where
µ = ( 1−1) , Σ = ( 1 0.50.5 1 ) .
Conditional on X , the substitution variable A was generated from a Bernoulli distribution such
that pr(A = 1 ∣X) = expit(XTu), where u = (1,1,1)T /2. The exposure variable Z was generated
following a logistic model: pr(Z = 1 ∣X,A) = expit(δ1Xu + δ1A), where δ1 is a parameter taking
values 0 or 1. The survival type G was generated from a multinomial distribution such
that pr(G = LL ∣X,A) = expit(γ0 +XT γ1 +Aγ2)expit(β10 +XTβ11 +Aβ12), pr(G = LD ∣X,A) ={1 − expit(γ0 +XT γ1 +Aγ2)} expit(β10 +XTβ11 +Aβ12) and pr(G = DD ∣X,A) = 1 − expit(β10 +
XTβ11 +Aβ12), where (β10, β11, β12) = (4, δ2, δ2, δ2,2)/2, (γ0, γ1, γ2) = (0,−3δ2, δ2, δ2,2)/2 and δ2
is a parameter taking values 0 or 1. The potential outcomes Y (z) were generated from the following
normal distributions: Y (1) ∣ G = LL,X,A ∼ N(XTu,0.52), Y (1) ∣ G = LD,X,A ∼ N(1 +XTu,0.52)
and Y (0) ∣ G = LL,X,A ∼ N(−1 +XTu,0.52). The observed survival S and observed outcome Y
follow from these by the consistency assumption. Note under our settings, the treatment assignment and
outcome are confounded when δ1 = 1, whereas the survival and outcome processes are confounded when
δ2 = 1. The true value for ∆LL is 1.
We compared four methods for estimating ∆LL: linear regression of Y on Z, X and A among observed
survivors; the estimation method of Ding et al. (2011); the proposed method under the exclusion restriction
assumption A.4, i.e., the estimation method using M.1–M.4; the proposed method under the no-interaction
assumption A.7, i.e., the estimation method using M.3, M.4 and M.7. We differ from Ding et al. (2011)
in both the identification conditions and the estimation method. Table 2 summarizes the results. The
naive regression method is biased in all settings due to selection bias. In the presence of confounding
between Z and Y or S and Y , that is, when δ1 ≠ 0 or δ2 ≠ 0, Ding et al. (2011)’s estimator is inconsistent.
However, even in the absence of confounding betweenZ and Y or S and Y , that is, when δ1 = δ2 = 0, Ding
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Table 2: Bias times 10 and standard error times 10 (in parenthesis) for various methods of estimating ∆LL
under settings following A.1–A.5. In these settings Prop-ER and Prop-NI are expected to be consistent.
Here δ1 = 1 and δ2 = 1 correspond to the presence of confounding between Z and Y , and the presence of
confounding between S and Y , respectively. Results are based on 500 simulated data sets
Exclusion restriction: True
Sample size δ1 δ2 Estimation method
Naive DGYZ Prop-ER Prop-NI
200 0 0 73(0.61) 3800(3300) 7.2(7.7) 32(1.9)
1 46(0.67) −1100(1000) 10(1.2) 2.9(0.91)
1 0 80(0.85) 160(4.7) −7.6(27) 45(2.4)
1 40(0.83) 35(8.4) 35(1.5) 28(1.2)
1000 0 0 73(0.27) 410(7.0) −4.3(1.5) 8.3(1.1)
1 48(0.29) −320(860) 3.3(0.56) 1.6(0.41)
1 0 80(0.36) 180(1.6) −8.3(3.5) 9.7(1.3)
1 41(0.36) 79(2.5) 11(0.97) 9.3(0.58)
5000 0 0 73(0.11) 380(2.1) −0.16(0.58) 1.7(0.48)
1 48(0.13) −1800(810) 0.72(0.27) 0.37(0.21)
1 0 81(0.17) 180(0.65) −1.1(0.62) 1.9(0.61)
1 41(0.16) 83(1.0) 2.6(0.50) 2.0(0.24)
Naive: linear regression among observed survivors; DGYZ: Ding et al. (2011)’s method; Prop-ER:
the proposed method assuming the exclusion restriction; Prop-NI: the proposed method assuming no
interaction.
et al. (2011)’s estimator can be unstable, especially if the sample size is small. Although in this case the
substitution relevance assumption of Ding et al. (2011) holds since pr(G = LL ∣ Z = 1, S = 1,A = 1) ≠
pr(G = LL ∣ Z = 1, S = 1,A = 0), for some simulated samples the estimates of pr(G = LL ∣ Z = 1, S =
1,A = 1) can be very close to the estimates of pr(G = LL ∣ Z = 1, S = 1,A = 0), leading to instability
in the causal effect estimates. In contrast, the proposed estimators are more stable, and have bias that
decreases with sample size in all the settings considered here.
5⋅2. Settings with exclusion restriction violation
We now evaluate the sensitivity of the proposed method to departures from the exclusion
restriction assumption A.4. We generated data in the same way as in Section 5⋅1, except
that the potential outcome Y (z) was generated from the following normal distributions: Y (1) ∣
G = LL,X,A ∼ N(5 +XTu +A,0.52), Y (1) ∣ G = LD,X,A ∼ N(7 +XTu +A,0.52) and Y (0) ∣ G =
LL,X,A ∼ N(4 +XTu +A,0.52). The method of Ding et al. (2011) for dealing with exclusion
restriction violations is not applicable here as it requires the substitution variableA to be either continuous
or have at least three categories.
The simulation results are presented in Table 3. As expected, the proposed estimator assuming no
interaction is consistent for all simulation settings considered here, whereas both Ding et al. (2011)’s
estimator and the proposed estimator assuming the exclusion restriction are biased for estimating ∆LL.
6. APPLICATION TO A SOUTHWEST ONCOLOGY GROUP TRIAL
We illustrate the advantage of the proposed methods using data from a randomized phase III trial to
compare docetaxel plus estramustine with mitoxantrone plus prednisone in men with metastatic, hormone
independent prostate cancer (Petrylak et al., 2004). The data set we use, which was created by Ding et al.
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Table 3: Bias times 100 and standard error times 100 (in parenthesis) for various methods of estimating
∆LL under settings with exclusion restriction violation. In these settings Prop-NI is expected to be
consistent but Prop-ER is not. Here δ1 = 1 and δ2 = 1 correspond to the presence of confounding between
Z and Y , and the presence of confounding between S and Y , respectively. Results are based on 500
simulated data sets
Exclusion restriction: False
Sample size δ1 δ2 Estimation method
Naive DGYZ Prop-ER Prop-NI
200 0 0 73(0.61) 5500(4700) 160(11) 32(1.9)
1 46(0.67) −1700(1500) 16(1.7) 2.9(0.91)
1 0 80(0.85) 66(7.6) 140(13) 45(2.4)
1 40(0.83) −140(13) 54(2.0) 28(1.2)
1000 0 0 73(0.27) 580(10) 160(1.9) 8.3(1.1)
1 48(0.29) −540(1300) 8.1(0.62) 1.6(0.41)
1 0 80(0.36) 94(2.4) 170(5.3) 9.7(1.3)
1 41(0.36) −62(3.8) 31(1.6) 9.3(0.58)
5000 0 0 73(0.11) 540(3.1) 160(0.69) 1.7(0.48)
1 48(0.13) −2800(1200) 4.7(0.27) 0.37(0.21)
1 0 81(0.17) 95(0.94) 160(0.77) 1.9(0.61)
1 41(0.16) −56(1.6) 20(0.47) 2.0(0.24)
Naive: linear regression among observed survivors; DGYZ: Ding et al. (2011)’s method; Prop-ER:
the proposed method assuming the exclusion restriction; Prop-NI: the proposed method assuming no
interaction.
(2011), contains observations on 487 men aged from 47 to 88. Of these subjects, 258 were randomly
assigned to receive docetaxel plus estramustine and 229 were randomly assigned to receive mitoxantrone
plus prednisone. In our analysis, we are interested in comparing these two treatments in terms of the health
related quality of life one year after receiving the treatment.
A naive analysis shows that among patients who survived to one year after receiving the assigned
treatment, the quality of life for those assigned to the docetaxel plus estramustine group is higher by
2.46 units compared to those assigned to the mitoxantrone plus prednisone group; the 95% confidence
interval is [−3.31,8.24]. However, this estimate is not causally interpretable as subjects who would survive
if assigned to docetaxel plus estramustine are potentially different from subjects who would survive if
assigned to mitoxantrone plus prednisone. Moreover, as reported by Petrylak et al. (2004), docetaxel
plus estramustine is beneficial for the overall survival compared to mitoxantrone plus prednisone. The
direct comparison among observed survivors is hence also subject to selection bias. Instead, we apply
Ding et al. (2011)’s and our proposed methods to deal with truncation due to death. To account for
possible common causes of the survival and outcome processes, we adjust for the following variables
in the proposed methods: age, race, type of prognosis, bone pain and performance status. Following Ding
et al. (2011), we use the baseline quality of life as the substitution variable, and the change in quality of
life in the one-year period as the outcome.
We first analyze this data set under the monotonicity assumption. The point estimates and bootstrap
standard errors are displayed in Table 4. The results in Ding et al. (2011) suggest that docetaxel plus
estramustine had a significant causal effect on the quality of life among those who would survive one year
after receipt of treatment regardless of which treatment group they were assigned to. In contrast, after
accounting for the baseline covariate information that might simultaneously impact the potential survival
and the potential quality of life, we were not able to reach such a conclusion. Both of the proposed methods
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Table 4: Survivor average causal effect of docetaxel plus estramustine on health related quality of life
Estimation method Point estimate Bootstrapped SE 2.5% 50% 97.5%
DGYZ 7.01 3.09 1.81 6.56 13.64
Prop-ER 3.06 11.79 −15.15 3.29 22.60
Prop-NI 2.73 3.82 −3.97 2.95 10.83
DGYZ: results adapted from Ding et al. (2011); Prop-ER: results estimated using the proposed method
assuming the exclusion restriction; Prop-NI: results estimated using the proposed method assuming no
interaction.
yield a point estimate that is much closer to 0, and their 95% confidence intervals cover 0. These results
show that, even in the setting of a randomized trial, adjusting for baseline covariates can lead to different
estimates for the survivor average causal effect; this should not be surprising since baseline variables may
confound S and Y .
The proposed estimator Prop-ER, that assumes the exclusion restriction and the monotonicity
assumption, is very unstable. In particular, the point estimate for the model parameter γ in M.4 is large
in magnitude, so that some fitted values of θ0/1 are close to the boundary. This indicates a monotonicity
violation. In fact, previous analyses also suggest that the monotonicity assumption might be problematic
for this data set (Ding et al., 2011) and as we discussed earlier, for randomized trials, the monotonicity
assumption is not plausible a priori. For these reasons, although the overall one year survival rate in the
docetaxel plus estramustine group (49.6%) is higher than that in the mitoxantrone plus prednisone group
(38.9%), a sensitivity analysis of the monotonicity assumption is warranted. In our analysis the sensitivity
parameter is piDL, which has a one-to-one correspondence with the sensitivity parameter ρ but has the
interpretation that it is the overall fraction of patients who would die one year after receiving docetaxel
plus estramustine but would survive one year after receiving mitoxantrone plus prednisone. Under our
modeling assumptions M.3 and M.6, the range for piDL is estimated to be [0.01,0.19], with the lower
and upper limits corresponding to ρ = 1 and 0, respectively. As the lower limit is greater than 0, the
monotonicity assumption A.1 is not compatible with these modeling assumptions. Figure 2 summarizes
the results from our sensitivity analysis. As both of the sensitivity lines cross 0, without prior knowledge
on the possible values for piDL, we cannot reach any definitive answer about the causal effect of docetaxel
plus estramustine versus mitoxantrone plus prednisone on the quality of life one year after receiving the
treatment. Furthermore, the two curves from the proposed methods agree approximately unless piDL is
smaller than 0.05. We also note that under a different set of assumptions, Ding et al. (2011) obtained
a value of piDL that is much greater than our upper bound. Under our modeling assumptions M.3 and
M.6, such a value is incompatible with the stochastic monotonicity assumption A.6, and would imply a
negative correlation between the potential survival under docetaxel plus estramustine and the potential
survival under mitoxantrone plus prednisone.
7. DISCUSSION
In this article, we considered the identification and estimation of the survivor average causal effect.
Compared with previous works that attempt to identify the survivor average causal effect using an
exogenous or instrumental variable, our method adjusts for baseline covariatesX , which may be common
causes between any pair of treatment, survival and outcome. This role for baseline covariates is unique to
our identification framework for the survivor average causal effect. In contrast to the standard estimation
problem of the average causal effect, even in randomized studies, the inclusion of baseline covariates is
crucial for obtaining unbiased estimates of the survivor average causal effect, since it is likely there is
confounding between survival and the post-survival outcome.
In our estimation approach, instead of imposing modeling assumptions on the observed data, we use
parametric models for the potential outcomes. This not only simplifies the estimation procedure, but also
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Fig. 2: Sensitivity analysis for estimating the survivor average causal effect in the Southwest Oncology
Group dataset. Solid line: the proposed method assuming the exclusion restriction; dashed line: the
proposed method assuming no interaction.
makes it easier to ensure compatibility between our identification and modeling assumptions. We also
propose alternative methods to relax the monotonicity assumption and the exclusion restriction. Formal
inference under our alternative assumption A.6 requires a sensitivity analysis framework that accounts for
uncertainty due to both non-identifiability and sampling variability, such as those based on ignorance and
uncertainty regions described by Vansteelandt et al. (2006) and others. To focus on the main ideas here
we only present point estimates under A.6 for fixed values of ρ.
In the current work we have only considered the binary exposure case. In practical medical studies, the
exposure variable may have multiple levels. For example, the smoking variable may be coded as never
smokers, past smokers and current smokers. In this case, it would be interesting to generalize the proposed
methods to deal with ordinal exposure status.
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SUPPLEMENTARY MATERIAL
Supplementary material available at Biometrika online includes proofs of theorems, propositions and
alternative causal diagrams that are compatible with the structural equations (4), but allow for certain
dependencies between error terms.
APPENDIX
A. Parameterizations under alternative identification assumptions
To estimate ∆LL under the assumptions of Theorem 2, we assume M.2, M.3 and the following model:
M.5 E{Y (0) ∣ Z = 0,X,G,A} is known up to a finite-dimensional parameter α3; that is, E{Y (0) ∣ Z =
0,X,G,A} =m3(X,G;α3), where G takes values in {LL,DL}, m3(⋅, ⋅;α3) is a known function
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and α3 is an unknown parameter. Note that due to condition (i) of Theorem 2, m3(⋅, ⋅;α3) does not
depend on the value of A. Specifically, for the simulations and data example we code LL to be 1,
DL to be 0, and consider
m3(X,G;α3) = α30 +XTα31 +Gα33.
M.6 pr{S(0) = 1 ∣X,A} is known up to a finite-dimensional parameter β0; that is pr{S(0) = 1 ∣
X,A} = θ0(X,A;β0), where θ0(⋅, ⋅;β0) is a known function and β0 is an unknown parameter.
Specifically, for the data example we consider
θ0(X,A;β0) = expit(β00 +XTβ01 +Aβ02).
Similarly, to estimate ∆LL under the assumptions of Theorem 3, we assume M.3, M.4 and the following
model:
M.7 E(Y ∣X,A,G,Z) is known up to a finite-dimensional parameter α4; that is, E[Y ∣X,A,G,Z] =
m4(X,A,G,Z;α4), whereG takes values in {LL,LD},m4(⋅, ⋅, ⋅, ⋅;α4) is a known function and α4
is an unknown parameter. Note that due to A.7, m4(X,A,G,Z;α4) should not contain interaction
terms within the pairs (A,Z) or (A,G). Specifically, for the simulations and data example we code
LL to be 1, LD to be 0 and consider
m4(X,A,G,Z;α4) = α40 +XTα41 +Aα42 +Gα43 +Zα44.
Finally, if one wishes to relax both the monotonicity assumption A.1 and the exclusion restriction A.4,
one may assume M.3, M.6, and the following model:
M.8 E(Y ∣X,A,G,Z) is known up to a finite-dimensional parameter α5; that is, E(Y ∣X,A,G,Z) =
m5(X,A,G,Z;α5), where G takes values in {LL,LD,DL}, m5(⋅, ⋅, ⋅, ⋅;α5) is a known function
and α5 is an unknown parameter. Note that due to A.7, m5(X,A,G,Z;α5) should not contain
interaction terms within the pairs (A,Z) or (A,G). Specifically, for the data example we code LL
to be 1, DL and LD to be 0 and consider
E(Y ∣X,A,G,Z) = α50 +XTα51 +Aα52 +ZGα53 +Zα54 + (1 −Z)Gα55.
REFERENCES
ANGRIST, J. D., IMBENS, G. W. & RUBIN, D. B. (1996). Identification of causal effects using instrumental
variables. Journal of the American Statistical Association 91, 444–455.
CHIBA, Y. & VANDERWEELE, T. J. (2011). A simple method for principal strata effects when the outcome has been
truncated due to death. American Journal of Epidemiology 173, 745–751.
DING, P., GENG, Z., YAN, W. & ZHOU, X.-H. (2011). Identifiability and estimation of causal effects by principal
stratification with outcomes truncated by death. Journal of the American Statistical Association 106, 1578–1591.
DING, P. & VANDERWEELE, T. J. (2014). Generalized cornfield conditions for the risk difference. Biometrika 101,
971–977.
EGLESTON, B. L., SCHARFSTEIN, D. O., FREEMAN, E. E. & WEST, S. K. (2007). Causal inference for
non-mortality outcomes in the presence of death. Biostatistics 8, 526–545.
FRANGAKIS, C. E. & RUBIN, D. B. (1999). Addressing complications of intention-to-treat analysis in the combined
presence of all-or-none treatment-noncompliance and subsequent missing outcomes. Biometrika 86, 365–379.
FRANGAKIS, C. E. & RUBIN, D. B. (2002). Principal stratification in causal inference. Biometrics 58, 21–29.
GILBERT, P. B., BOSCH, R. J. & HUDGENS, M. G. (2003). Sensitivity analysis for the assessment of causal vaccine
effects on viral load in HIV vaccine trials. Biometrics 59, 531–541.
HANSEN, L. P. (1982). Large sample properties of generalized method of moments estimators. Econometrica 50,
1029–1054.
HAYDEN, D., PAULER, D. K. & SCHOENFELD, D. (2005). An estimator for treatment comparisons among survivors
in randomized trials. Biometrics 61, 305–310.
IMAI, K. (2008). Sharp bounds on the causal effects in randomized experiments with truncation-by-death. Statistics
& Probability Letters 78, 144–149.
IMBENS, G. W. (2000). The role of the propensity score in estimating dose-response functions. Biometrika 87,
706–710.
14 L. WANG, X. ZHOU AND T. RICHARDSON
IMBENS, G. W. (2003). Sensitivity to exogeneity assumptions in program evaluation. American Economic Review
93, 126–132.
JEMIAI, Y., ROTNITZKY, A., SHEPHERD, B. E. & GILBERT, P. B. (2007). Semiparametric estimation of treatment
effects given base-line covariates on an outcome measured after a post-randomization event occurs. Journal of the
Royal Statistical Society, Series B: Methodological 69, 879–901.
KURLAND, B. F., JOHNSON, L. L., EGLESTON, B. L. & DIEHR, P. H. (2009). Longitudinal data with follow-up
truncated by death: Match the analysis method to research aims. Statistical Science 24, 211–222.
LEE, K., DANIELS, M. J. & SARGENT, D. J. (2010). Causal effects of treatments for informative missing data due
to progression/death. Journal of the American Statistical Association 105, 912–929.
LONG, D. M. & HUDGENS, M. G. (2013). Sharpening bounds on principal effects with covariates. Biometrics 69,
812–819.
PEARL, J. (2009). Causality. Cambridge: Cambridge University Press.
PETRYLAK, D. P., TANGEN, C. M., HUSSAIN, M. H., LARA JR, P. N., JONES, J. A., TAPLIN, M. E., BURCH,
P. A., BERRY, D., MOINPOUR, C., KOHLI, M. et al. (2004). Docetaxel and estramustine compared with
mitoxantrone and prednisone for advanced refractory prostate cancer. New England Journal of Medicine 351,
1513–1520.
ROBINS, J. M. (1986). A new approach to causal inference in mortality studies with a sustained exposure period –
application to control of the healthy worker survivor effect. Mathematical Modelling 7, 1393–1512.
ROBINS, J. M. (2003). Semantics of causal DAG models and the identification of direct and indirect effects. In
Highly structured stochastic systems, P. J. Green, N. L. Hjort & S. Richardson, eds. Oxford University Press: New
York, NY, pp. 70–81.
ROBINS, J. M. & GREENLAND, S. (1992). Identifiability and exchangeability for direct and indirect effects.
Epidemiology 3, 143–155.
ROBINS, J. M. & RICHARDSON, T. S. (2010). Alternative graphical causal models and the identification of direct
effects. In Causality and psychopathology: Finding the determinants of disorders and their cures, P. Shrout, K. M.
Keyes & K. Ornstein, eds. Oxford University Press: New York, NY, pp. 103–158.
ROSENBAUM, P. R. (1984). The consequences of adjustment for a concomitant variable that has been affected by the
treatment. Journal of the Royal Statistical Society, Series A: General 147, 656–666.
ROSENBAUM, P. R. & RUBIN, D. B. (1983). Assessing sensitivity to an unobserved binary covariate in an
observational study with binary outcome. Journal of the Royal Statistical Society, Series B: Methodological 45,
212–218.
ROY, J., HOGAN, J. W. & MARCUS, B. H. (2008). Principal stratification with predictors of compliance for
randomized trials with 2 active treatments. Biostatistics 9, 277–289.
RUBIN, D. B. (1980). Comment. Journal of the American Statistical Association 75, 591–593.
RUBIN, D. B. (1998). More powerful randomization-based p-values in double-blind trials with non-compliance.
Statistics in Medicine 17, 371–385.
RUBIN, D. B. (2000). Comment on “causal inference without counterfactuals”. Journal of the American Statistical
Association 95, 435–438.
RUBIN, D. B. (2006). Causal inference through potential outcomes and principal stratification: Application to studies
with “censoring” due to death. Statistical Science 21, 299–309.
SHEPHERD, B. E., GILBERT, P. B., JEMIAI, Y. & ROTNITZKY, A. (2006). Sensitivity analyses comparing outcomes
only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine
trials. Biometrics 62, 332–342.
SPERLING, R., MORMINO, E. & JOHNSON, K. (2014). The evolution of preclinical Alzheimer’s disease:
implications for prevention trials. Neuron 84, 608–622.
TCHETGEN TCHETGEN, E. J. (2014). Identification and estimation of survivor average causal effects. Statistics in
Medicine 33, 3601–3628.
VANSTEELANDT, S., GOETGHEBEUR, E., KENWARD, M. G. & MOLENBERGHS, G. (2006). Ignorance and
uncertainty regions as inferential tools in a sensitivity analysis. Statistica Sinica 16, 953–979.
WEUVE, J., TCHETGEN TCHETGEN, E. J., GLYMOUR, M. M., BECK, T. L., AGGARWAL, N. T., WILSON, R. S.,
EVANS, D. A. & DE LEON, C. F. M. (2012). Accounting for bias due to selective attrition: the example of
smoking and cognitive decline. Epidemiology 23, 119.
ZHANG, J. L. & RUBIN, D. B. (2003). Estimation of causal effects via principal stratification when some outcomes
are truncated by “death”. Journal of Educational and Behavioral Statistics 28, 353–368.
Supplementary Materials for “Identification and Estimation of Causal
Effects with Outcomes Truncated by Death”
Linbo Wang, Xiao-Hua Zhou and Thomas Richardson
SUMMARY
In this Supplementary Material we provide proofs of theorems and propositions in the paper, and
alternative causal diagrams that are compatible with the structural equations (4) in the paper, but allow for
certain dependencies between error terms. Some additional equations and figures are created within this
document, which we label as equation (S1), Figure S1 and so forth, to distinguish them from those in the
main text.
1. PROOF OF THEOREMS 1–3
By definition, ∆LL = E{Y (1) ∣ G = LL} −E{Y (0) ∣ G = LL}, where E{Y (z) ∣ G = LL} is given in
(1). It then suffices to identify piLL∣W and µz,LL,W for identification of ∆LL.
Identification of piLL∣W : under the assumptions of Theorem 1 or 3, piLL∣W can be identified from (2),
whereas under the assumptions of Theorem 2, piLL∣W can be identified from the following equations:
pr{S(1) = 1 ∣W} = pr(S = 1 ∣ Z = 1,W ) = piLL∣W + piLD∣W ;
pr{S(0) = 1 ∣W} = pr(S = 1 ∣ Z = 0,W ) = piLL∣W + piDL∣W ;
piLL∣W = pr{S(0) = 1 ∣W}pr{S(1) = 1 ∣ S(0) = 1,W};
pr{S(1) = 1 ∣ S(0) = 1,W} = pr{S(1) = 1 ∣W}
+ ρ(W )(min [1, pr{S(1) = 1 ∣W}
pr{S(0) = 1 ∣W}] − pr{S(1) = 1 ∣W}) ,
where due to A.2, pr{S(z) = 1 ∣W} = pr(S = 1 ∣ Z = z,W ) and thus is identifiable for z = 0,1. Note that
under these assumptions, pig∣W is also identifiable with g ∈ {LD,DL,DD}.
Identification of µz,LL,W : under the assumptions of Theorem 1, µ0,LL,W can be identified from (3). First
recall that W = (A,X). As described above, pg∣z,w,s=1 = pr(G = g ∣X = x,A = a)/pr(S = 1 ∣ Z = z,X =
x,A = a) is identifiable from the observed data. Note that by consistency, 0 = pDL∣1,x,a,s=1 = pLD∣0,x,a,s=1 =
pDD∣z,x,a,s=1, z ∈ {0,1}. Furthermore, A.5 implies that for all x, there exist a0 ≠ a1 such that pLL∣1,x,a1,s=1 ≠
pLL∣1,x,a0,s=1. Due to A.4, for g = LL,LD,
µ1,g,w = E(Y ∣ Z = 1,G = g,X = x,A = a) = E(Y ∣ Z = 1,G = g,X = x) ≡ µ1,g,x.
Furthermore, µ1,LL,x can be identified from
E(Y ∣ Z = 1, S = 1,X = x,A = a1) = pLL∣1,x,a1,s=1µ1,LL,x + (1 − pLL∣1,x,a1,s=1)µ1,LD,x,
E(Y ∣ Z = 1, S = 1,X = x,A = a0) = pLL∣1,x,a0,s=1µ1,LL,x + (1 − pLL∣1,x,a0,s=1)µ1,LD,x. (S1)
Under the assumptions of Theorem 2, we can obtain similarly that for z ∈ {0,1}, µz,LL,w = µz,LL,x,
where µ1,LL,x is identified by (S1), and µ0,LL,x can be identified from
E(Y ∣ Z = 0, S = 1,X = x,A = a′1) = pLL∣0,x,a′1,s=1µ0,LL,x + (1 − pLL∣0,x,a′1,s=1)µ0,DL,x,
E(Y ∣ Z = 0, S = 1,X = x,A = a′0) = pLL∣0,x,a′0,s=1µ0,LL,x + (1 − pLL∣0,x,a′0,s=1)µ0,DL,x,
where a′1 and a′0 are two distinct values of A such that pLL∣0,x,a′1,s=1 ≠ pLL∣0,x,a′0,s=1.
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Similarly, under the assumptions of Theorem 3, µ0,LL,W is identified by (3) and µ1,LL,x,a1 can be
identified from the following equations:
E(Y ∣ Z = 1, S = 1,X = x,A = a1) = pLL∣1,x,a1,s=1µ1,LL,x,a1 + (1 − pLL∣1,x,a1,s=1)µ1,LD,x,a1 ;
E(Y ∣ Z = 1, S = 1,X = x,A = a0) = pLL∣1,x,a0,s=1µ1,LL,x,a0 + (1 − pLL∣1,x,a0,s=1)µ1,LD,x,a0 ;
µ1,LL,x,a1 − µ1,LL,x,a0 = µ1,LD,x,a1 − µ1,LD,x,a0 ;
µ1,LL,x,a1 − µ1,LL,x,a0 = µ0,LL,x,a1 − µ0,LL,x,a0 ;
E(Y ∣ Z = 0, S = 1,X = x,A = a1) = µ0,LL,x,a1 ;
E(Y ∣ Z = 0, S = 1,X = x,A = a0) = µ0,LL,x,a0 ,
where µz,g,x,a ≡ E(Y ∣ Z = z,G = g,X = x,A = a).
For any a ∈ A / {a1}, µ1,LL,x,a can be identified via the following equations:
µ1,LL,x,a − µ1,LL,x,a1 = µ0,LL,x,a − µ0,LL,x,a1 ;
E(Y ∣ Z = 0, S = 1,X = x,A = a) = µ0,LL,x,a;
E(Y ∣ Z = 0, S = 1,X = x,A = a1) = µ0,LL,x,a1 .
2. PROOF THAT THE NONPARAMETRIC STRUCTURAL EQUATION MODEL WITH INDEPENDENT
ERRORS IN SECTION 3.3 IMPLIES A.2–A.4
Under (4), Z⊥⊥(X , A, S , Y ) implies that Z⊥⊥(S , Y ) ∣X,A, which then implies A.2 and A.3;
recall here that the error terms can be interpreted as the set of one-step-ahead counterfactuals. To see that
A.4 holds under the structural equations (4), note the following:
pr{Y ∣ A = a1, Z = 1,X = x,S(1) = 1, S(0)} = pr{Y ∣ A = a1, Z = 1,X = x,S = 1, S(0)}= pr(Y ∣ A = a1, Z = 1,X = x,S = 1)= pr(Y ∣ A = a0, Z = 1,X = x,S = 1)= pr{Y ∣ A = a0, Z = 1,X = x,S = 1, S(0)}= pr{Y ∣ A = a0, Z = 1,X = x,S(1) = 1, S(0)},
where the first and last lines follow from consistency; the second and fourth follow from Y⊥⊥S(0) ∣
A,Z = 1,X,S = 1, which holds as Y is d-separated from S given X,A,Z,S; the third line follows since
Y is d-separated from A conditioning on X,Z,S.
As A.4 holds trivially for the subgroup with S(1) = 0, we complete the proof.
3. PROOF OF PROPOSITION 1
Constraint (8) is standard. To prove (9), note that under A.4, (S1) holds for all a, i.e.
E(Y ∣ Z = 1, S = 1,X = x,A = a) = pLL∣1,x,a,s=1µ1,LL,x + (1 − pLL∣1,x,a,s=1)µ1,LD,x. (S2)
It follows that ∣E(Y ∣ Z = 1, S = 1,X = x,A = a)∣ ≤ max(∣µ1,LL,x∣, ∣µ1,LD,x∣).
Hence for all x, E(Y ∣ Z = 1, S = 1,X = x,A = a) is bounded as a function of a. On the other hand,
suppose that for all x, E(Y ∣ Z = 1, S = 1,X = x,A = a) is bounded as a function of a. Let
f¯(x) = sup
a
E(Y ∣ Z = 1, S = 1,X = x,A = a), and
¯
f(x) = inf
a
E(Y ∣ Z = 1, S = 1,X = x,A = a).
Then (S2) holds with
pLL∣1,x,a,s=1 = f¯(x) −E(Y ∣ Z = 1, S = 1,X = x,A = a)
f¯(x) −
¯
f(x) , µ1,LL,x = ¯f(x) and µ1,LD,x = f¯(x).
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Hence (9) summarizes all the constraints on the observed data law derived from (S2). The proof of (11) is
similar and hence omitted.
Constraint (10) follows immediately from A.5 by noting that
pr(S = 1 ∣ Z = 0,X = x,A = a)
pr(S = 1 ∣ Z = 1,X = x,A = a) = pr(G = LL ∣X = x,A = a)pr(S = 1 ∣ Z = 1,X = x,A = a)= pr(G = LL ∣ Z = 1, S = 1,X = x,A = a).
To show (12), note that A.7 implies that for all a1, a0,
µ1,LL,x,a1 − µ0,LL,x,a1 = µ1,LL,x,a0 − µ0,LL,x,a0 ,
µ1,LD,x,a1 − µ0,LL,x,a1 = µ1,LD,x,a0 − µ0,LL,x,a0 .
It follows that µ1,LL,w − µ0,LL,w = µ1,LL,x − µ0,LL,x and µ1,LD,w − µ0,LL,w = µ1,LD,x − µ0,LL,x. We then
have
E(Y ∣ Z = 1, S = 1,X = x,A = a) −E(Y ∣ Z = 0, S = 1,X = x,A = a)= pLL∣1,x,a,s=1µ1,LL,x,a + pLD∣1,x,a,s=1µ1,LD,x,a − µ0,LL,x,a= pLL∣1,x,a,s=1(µ1,LL,x,a − µ0,LL,x,a) + pLD∣1,x,a,s=1(µ1,LD,x,a − µ0,LL,x,a)= pLL∣1,x,a,s=1(µ1,LL,x − µ0,LL,x) + pLD∣1,x,a,s=1(µ1,LD,x − µ0,LL,x)
so that ∣E(Y ∣ Z = 1, S = 1,X = x,A = a) −E(Y ∣ Z = 0, S = 1,X = x,A = a)∣≤ max(∣µ1,LL,x − µ0,LL,x∣, ∣µ1,LD,x − µ0,LL,x∣).
The rest of the proof is similar to that for (9) and is hence omitted.
4. ALTERNATIVE CAUSAL DIAGRAMS
Figure S1 shows some more complicated causal diagrams that imply assumptions A.2–A.4 but allow
for dependence of errors in the structural equations (4) representing unmeasured confounding between
nodes in Fig. 1. Here unmeasured confounding is denoted by a bi-directed edge between observed nodes.
In general, using graphical terminology (?), the mixed graphs, such as those in Fig. S1, imply A.2–A.4
so long as the pairs (Z,S), (Z,Y ), (A,Y ) and (S,Y ) are not in the same district, where a district is a
connected component of the graph obtained by removing all edges that are not bi-directed. Specifically,
A.2 requires that Z and S cannot be in the same district, A.3 requires that neither Z and Y nor S and Y
can be in the same district, and A.4 requires additionally that A and Y cannot be in the same district.
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Fig. S1: More complicated causal diagrams that imply A.2–A.4. The districts in these graphs are: (i){X,A,Z},{S} and {Y }; (ii) {X,A,S},{Z} and {Y }; (iii) {X,Y },{A,Z} and {S}.
